SCM
IRD

Sterling Capital Management’s Opus Genetics IRD Stock Holding History

Sterling Capital Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$773 Buy
+188
New +$877 ﹤0.01% 3174

Other funds holding IRD

JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
FCCM
First City Capital Management Savannah, Georgia $206M AUM 26.13% 1-Year Est. Return
HHCP
Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
GF
GGM Financials Columbus, Ohio $264M AUM 15.28% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sterling Capital Management's IRD Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Opus Genetics (IRD) in Q2 2026: 188 shares worth $773. The stake represents ﹤0.01% of the portfolio and ranks #3174 among its holdings.

11 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Sterling Capital Management held 188 shares of Opus Genetics worth $773 as of Q2 2026.
  • Opus Genetics was a new Sterling Capital Management position in Q2 2026.
  • Opus Genetics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3174 holding.
  • 11 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.